By JRF Ortho
Knee pain in active patients over 40 is often difficult to treat but according to researchers presenting their work today at the American Orthopaedic Society for Sports Medicine’s (AOSSM) Annual Meeting in San Diego, utilizing a special kind of allograft may be a step in the right direction.
“Our findings note that patients older than 40 may benefit from using a fresh osteochondral allograft transplantation to treat focal cartilage defects, a common cause of knee pain in adults,” said lead author, Dennis Crawford, MD, PhD from the Oregon Health and Science University in Portland, Oregon.
Crawford and his colleagues looked at a total of 80 patients broken into two groups. The study group consisted of 38 patients, 10 women and 28 men who were at least 40 years of age and a control group with 42 patients (27 men and 15 women) who were 39 years of age or younger.
A statistically significant improvement for both groups was noted for the final follow-up for IKDC and all five KOOS sub-scores. Greatest changes were seen in the ability of patients to perform Sports and with improvement in healthful daily activity. Previous surgical treatment was performed on 31 of 38 knees in the study group and 37 of the 42 knees in the control group.
“This type of osteochondral allograft transplantation has traditionally been used in younger active patients with cartilage disorders. However, seeing this type of success allows sports medicine physicians another option in older patients and serves as a predictable biologic joint preservation technique,” said Crawford.
From JRF Ortho News– “Allograft use is one of the hottest topics [in the United States] right now,” said Christopher Harner, MD, of Pittsburgh, U.S.A., in a special symposium on allografts at the 7th European Federation of National Associations of Orthopaedics and Traumatology Congress (EFORT). Harner was joined by fellow orthopaedic surgeons Gary G. Poehling, MD, of Winston-Salem, U.S.A., and René Verdonk, MD, PhD, of Gent, Belgium, a member of the Orthopaedics Today International Editorial Advisory Board.
“There has been an explosion in the use of musculoskeletal allografts in sports medicine, and last year more than 1 million graphs were distributed,” Harner said. “Although the tissues improved in safety in the last 10 to 15 years and disease transmission is rare, it still exists.”
Harner said the advantages of allografts include low donor site mobility, decreased operating time and less pain in the first six weeks. He called it the preferred procedure in complex cases such as multiple ligament revision cases. He said the disadvantages include disease transmission and slow incorporation.
Click here to read the entire article.
JRF Ortho specializes in providing orthopedic surgeons with the highest viability, most widely available cartilage solutions in the industry. Our goal is to provide innovative solutions for allograft joint repair to orthopedic surgeons who specialize in helping patients regain movement and improve their quality of life; thus, JRF Ortho is redefining the standard for allograft joint repair and maximizing the gift of donation.
Our unique member relationship with AlloSource® and Community Tissue Services® (CTS) enables us to offer the largest selection of specialized high-viability fresh osteochondral grafts, tendons and menisci in the industry. Through innovation and a commitment to clinical results and positive outcomes, JRF Ortho is redefining the standard for allograft joint repair.
Our mission is to improve quality of life through innovative solutions for allograft joint repair.
Why We Are Different
At JRF Ortho, we provide innovative solutions for allograft joint repair to orthopedic surgeons who specialize in helping patients regain movement and improve their quality of life. Through our unique member relationship with AlloSource and Community Tissue Services, we offer the largest selection of specialized high-viability fresh osteochondral grafts, tendons and menisci in the industry.
Our approach to joint restoration maximizes tissue safety and availability for elective procedures. Through our commitment to superior clinical results and positive patient outcomes, JRF Ortho is redefining the standard for allograft joint repair and maximizing the gift of donation. Read more>>>